Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 202821-81-6 Chemical Structure| 202821-81-6

Structure of BMS-191011
CAS No.: 202821-81-6

Chemical Structure| 202821-81-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-191011 (BMS-A) is an opener of the large-conductance, Ca2+-activated potassium (maxi-K) channel, effective in stroke models. It has also shown neuroprotective properties in two distinct animal models of stroke- MCAO in the SHR rat and a normotensive model of focal stroke.

Synonyms: BMS-A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-191011

CAS No. :202821-81-6
Formula : C16H10ClF3N2O3
M.W : 370.71
SMILES Code : O=C1OC(C2=CC=C(C(F)(F)F)C=C2)=NN1CC3=CC(Cl)=CC=C3O
Synonyms :
BMS-A
MDL No. :MFCD09753285
InChI Key :QKOWACXSXTXRKA-UHFFFAOYSA-N
Pubchem ID :10474339

Safety of BMS-191011

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H413
Precautionary Statements:P301+P310
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCC1143 cells 20 µM 2 days To study the effect of BMS-191011 on the growth of HCC1143 cells, results showed that BMS-191011 inhibited cell growth. BMC Cancer. 2020 Jun 26;20(1):595
SUM159 cells 20 µM 2 days To study the effect of BMS-191011 on the growth of SUM159 cells, results showed that BMS-191011 inhibited cell growth. BMC Cancer. 2020 Jun 26;20(1):595
MDA-MB-231 cells 10-50 µM 5 days To study the effect of NS11021 on the growth of MDA-MB-231 cells, results showed that NS11021 induced cell death within 5 days. BMC Cancer. 2020 Jun 26;20(1):595
HEK293T cells 10 μM BMS-191011 attenuated GAL-021-mediated suppression of BK Ca-channel activity Biomolecules. 2020 Jan 25;10(2):188
rat cerebral artery smooth muscle cells 3 µM To investigate the effect of BMS-191011 on BK Ca channels in rat cerebral artery smooth muscle cells, results showed that BMS-191011 induced relaxation, which was inhibited by apelin. J Cardiovasc Pharmacol. 2018 Apr;71(4):223-232

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CBA/CaJ mice Salicylate-induced tinnitus model Intraperitoneal injection 0.5 mg/kg Single dose, 1 hour before testing BMS-191011 treatment reduced behavioral manifestations of SS-induced tinnitus but did not influence SS-induced increases in auditory brainstem response functions. Local application at the inferior colliculus reversed SS-suppressed spontaneous activity, particularly in the frequency region of the tinnitus percept. Front Neurosci. 2022 Aug 25;16:763855
Mice High-dosage vitamin D3-induced vascular calcification model Intraperitoneal injection 10 mg/kg Once daily for the first 5 days BK channel activator BMS191011 significantly ameliorated high-dosage vitamin D3-induced vascular calcification in mice, reducing calcium deposition and content, decreasing Runx2 mRNA and protein expression, and increasing α-SMA mRNA and protein levels Acta Pharmacol Sin. 2022 Mar;43(3):624-633.
NSG mice MDA-MB-231 xenograft model Intratumoral injection 100 μg/kg Twice a week for 4 weeks To study the effect of BK channel opener on the growth of MDA-MB-231 xenograft tumors, results showed that BK channel opener significantly slowed tumor growth. BMC Cancer. 2020 Jun 26;20(1):595

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.70mL

0.54mL

0.27mL

13.49mL

2.70mL

1.35mL

26.98mL

5.40mL

2.70mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories